Warnings Mounjaro may cause tumors in the thyroid, including thyroid cancer
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Overview In Europe, many countries are adopting GLP-1 drugs as a key treatment for blood sugar control and weight management
A higher risk of deficiency is present in patients with malabsorptive syndrome and/or unusually low sun exposure, those who have undergone gastric bypass surgery, or those on prolonged glucocorticoid use (which alters intestinal absorption) ( Cancer patients may have a higher risk of deficiency due to causes of intestinal fat malabsorption (i.e., intestinal surgery, pancreatectomy, gastrectomy) or due to oncologic treatments, such as aromatase inhibitors
Further studies investigating the effect of these factors are needed to determine and refine the predictive value of this and other HRM metrics for pathological reflux among LT candidates
The Rise of GLP-1 Food Products: Nutritional Benefits, Ingredients and Foods to Avoid GLP-1 (Glucagon-like peptide-1) food products have started to attract more interest as people look for ways to manage their appetite and look after their health
they can advise on whether a temporary pause is best for your recovery
